Bentham Science Logo

Track Your Manuscript:


Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly: Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 21, 12 Issues, 2021
ISSN: 2212-3873 (Online)
ISSN: 1871-5303 (Print)
This journal supports open access

Most Accessed Articles













Effect of Estrogen and Progesterone Hormones on the Expression of Angiotensin II Receptors in the Heart and Aorta of Male Rats

, 2021; 21(8): 1504-1511.

Bahaa Al‑Trad*, Osama Abu-alrob, Yousf Jaradat, Mazhar Al-Zoubi, Almuthanna K. Alkarki, Alaa A A Aljabali, Janti Qar, Sahar Omari, Malek Shehab and Bahja Kanan


DOI: 10.2174/1871530320666201023124544


Can Cytokines be used as an Activation Marker in Rheumatoid Arthritis?

, 2021; 21(8): 1459-1465.

Fatih Öner Kaya, Yeşim Ceylaner, Belkız Öngen İpek, Zeynep Güneş Özünal, Gülbüz Sezgin and Selim Nalbant*


DOI: 10.2174/1871530320666201019115030









Editor-in-Chief

Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
(Italy)
Biography
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets - Immune, Endocrine & Metabolic Disorders was launched in 2001 and later renamed in 2006 as Endocrine, Metabolic & Immune Disorders - Drug Targets.

Related Journals

Related eBooks

eBooks Catalog